Early treatment of obstructive apnoea and stroke outcome: A randomised controlled trial

European Respiratory Journal

Volumn 37, Issue 5, 2011, Pages 1128-1136

  Parra, O ^a,b   Sanchez Armengol A ^c   Bonnin, M ^a   Arboix, A ^a,b   Campos Rodriguez F ^d   Perez Ronchel J ^d   Duran Cantolla J ^b,e   De La Torre, G ^e   Gonzalez Marcos J R ^f   De La Pena M ^g   Carmen Jimenez M ^g   Masa, F ^b,h   Casado, I ^h   Luz Alonso, M ^b,i   Macarron J L ^j  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Unidad de Trastornos Respiratorios del Sueño   (Spain)

^d HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

ⁱ Unidad de Sueño   (Spain)

^j HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

more..

Author keywords

Cardiovascular events; Ischaemic stroke; Mortality; Nasal continuous positive airway pressure; Neurologic outcome; Quality of life

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EARLY INTERVENTION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUALITY OF LIFE; RECURRENCE; SLEEP APNEA, OBSTRUCTIVE; STROKE; TREATMENT OUTCOME;

EID: 79955662595     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00034410     Document Type: Article

References (54)

1. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 149-157.
2. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053. (Pubitemid 40386782)
3. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 31: 1071-1078.
4. Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke 1997; 28: 1765-1772. (Pubitemid 27391447)
5. Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447-1451. (Pubitemid 43069819)
6. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000; 161: 375-380. (Pubitemid 30129441)
7. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25. (Pubitemid 32095247)
8. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-2041. (Pubitemid 41609096)
9. Good DC, Henkle JQ, Gelber D, et al. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27: 252-259. (Pubitemid 26044496)
10. Parra O, Arboix A, Montserrat JM, et al. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J 2004; 24: 267-272. (Pubitemid 39139795)
11. Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008; 168: 297-301. (Pubitemid 351281676)
12. Bålfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas.Am J Respir Crit Care Med 1994; 150: 1587-1591.
13. Drager LF, Bortolotto LA, Lorenzi MC, et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172: 613-618. (Pubitemid 41232973)
14. Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002; 165: 67-70. (Pubitemid 34053359)
15. Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid intimamedia thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172: 625-630. (Pubitemid 41232975)
16. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1: 862-865. (Pubitemid 11099316)
17. Montserrat JM, Ferrer M, Hernandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001; 164: 608-613. (Pubitemid 32801664)
18. Faccenda JF, Mackay TW, Boon NA, et al. Randomized placebo controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344-348. (Pubitemid 32158510)
19. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204-210. (Pubitemid 34113817)
20. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73. (Pubitemid 36070935)
21. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006; 129: 1459-1467. (Pubitemid 43894973)
22. Lattimore JL, Wilcox I, Skilton M, et al. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006; 61: 491-495. (Pubitemid 43901518)
23. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit CareMed 2007; 176: 706-712. (Pubitemid 47503079)
24. Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 175: 612-617. (Pubitemid 46438946)
25. Muñoz R, Doran-Cantilla J, Martínez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly stroke. Stroke 2006; 37: 2317-2321. (Pubitemid 44337176)
26. Wessendorf TE, Wang Y-M, Thilmann AF, et al. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur Respir J 2001; 18: 623-629. (Pubitemid 33040619)
27. Sandberg O, Franklin KA, Bucht G, et al. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J 2001; 18: 630-634. (Pubitemid 33040620)
28. Parra O. Sleep-disordered breathing and stroke: is there a rationale for treatment? Eur Respir J 2001; 18: 619-622.
29. Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006; 37: 967-972.
30. Harbison J, Ford GA, Gibson GJ. Nasal continuous positive airway pressure for sleep apnoea following stroke. Eur Respir J 2002; 19: 1216-1217.
31. Hui DS, Choy DK, Wong LK, et al. Prevalence of sleep-disordered breathing and continuous positive airway pressure compliance: results in chinese patients with first-ever ischemic stroke. Chest 2002; 122: 852-860.
32. Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol 2006; 13: 198-200.
33. Hsu CY, Vennelle M, Li HY, et al. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry 2006; 77: 1143-1149. (Pubitemid 44453248)
34. Martinez-Garcia MA, Soler-Cataluña JJ, Ejarque-Martinez L, et al. CPAP treatment reduces mortality in ischemic stroke patients with obstructive sleep apnea. Am J Respir Crit Care Med 2009; 180: 36-41.
35. Arboix A, Morcillo C, García-Erols L, et al. Different vascular risk factor profiles in ischemic stroke subtypes: a study from the "Sagrat Cor Hospital of Barcelona Stroke Registry". Acta Neurol Scand 2000; 102: 264-270.
36. Arboix A. Alvarez-Sabín J, Soler L, for the Cerebrovascular Study Group of the Spanish Society of Neurology. Nomenclatura de las enfermedades vasculares cerebrales. Neurologia 1998; 13: Suppl. 1, 1-10.
37. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med 1965; 14: 61-65.
38. Côté R, Battista RN, Shurvell BL, et al. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 1986; 17: 731-737. (Pubitemid 16066548)
39. Van Swieten JC,Koudstaal PJ,VisserMC, et al. Interobserver agreement for theassessmentofhandicapin strokepatients. Stroke 1988; 19:604-607.
40. Jenkinson C, Davies R, Mullins R, et al. Randomised prospective parallel trial of therapeutic nasal continuous positive airway pressure (NCPAP) against sub- therapeutic NCPAP for obstructive sleep apnoea. Lancet 1999; 353: 2100-2105. (Pubitemid 29278478)
41. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
42. MolinaM,Hernández L, Duran J, et al. Protocol to evaluate automatic continuous positive airway pressure. Assessment of the usefulness of the Autoset-T device to determine optimal pressure for treating sleep apnea/hypopnea syndrome. Arch Bronconeumol 2003; 39: 118-125.
43. Masa JF, Jiménez A, Durán J, et al. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 2004; 170: 1218-24. (Pubitemid 39577381)
44. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Sleep disordered breathing in community-dwelling elderly. Sleep 1991; 14: 486-495.
45. Calvin AD, Somers VK. Obstructive sleep apnea and risk of stroke: time for a trial. Nat Clin Pract Cardiovasc Med 2009; 6: 90-91.
46. Alarcón A, León C, Maimó A, et al. Compliance with nasal continuous positive airway pressure (CPAP) treatment in sleep apnea-hypopnea syndrome. Arch Bronconeumol 1995; 31: 56-61.
47. Iranzo A, Santamaría J, Berenguer J, et al. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology 2002; 58: 911-916. (Pubitemid 34242067)
48. Duncan PW, Wallace D, Lai SM, et al. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke 199, 30: 2131-2140.
49. Nishibayashi M, Miyamoto M, Miyamoto T, et al. Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. J Clin Sleep Med 2008; 15: 242-247. (Pubitemid 352039435)
50. Redline S, StraussME, Adams N, et al. Neuropsychological function in mild sleep-disordered breathing. Sleep 1997; 20: 160-167. (Pubitemid 27194754)
51. Barnes M, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170: 656-664. (Pubitemid 39202208)
52. Morrell MJ, McRobbie DW, Quest RA, et al. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med 2003; 4: 451-454. (Pubitemid 37193029)
53. Blanco M, Sobrino T, Montaner J, et al. Stroke with polyvascular atherothrombotic disease. Atherosclerosis 2010; 208: 587-592.
54. Scala R, Turkington PM, Wanklyn P, et al. Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: a pilot study. Respir Med 2009; 103: 59-66.